The short answer
Multi-cancer early detection blood tests are still experimental. None is FDA-approved, none has been shown to reduce cancer deaths, and a negative result does not rule out cancer.
As of July 2026 no multi-cancer early detection (MCED) test is FDA-approved. Galleri is sold as a laboratory-developed test; GRAIL submitted its premarket approval application in January 2026 and the FDA has not ruled on it.
"Detects more than 50 cancers" means the test was designed to look for signals from that many cancer types, not that it finds most cases of any of them.
In the UK NHS-Galleri trial of about 140,000 adults, the main goal was missed: there was no statistically significant reduction in cancers diagnosed at stage III or IV combined, and cancer deaths were not reported.
In PATHFINDER 2, about 0.4% of people without cancer got a positive result, but only 173 of the 440 cancers diagnosed in the study were found by the blood test.
Choose how you want to understand this
The full explanation.
The claim
One blood test, drawn at a routine visit, that finds more than 50 cancers years before you feel anything. That is how multi-cancer early detection (MCED) tests are usually described in ads and news stories.
What these tests actually do
MCED tests look for fragments of DNA that tumors shed into the blood, mainly by reading chemical tags called methylation patterns. If the pattern looks like cancer, the test reports that a cancer signal was detected, and it often guesses which organ the signal came from. It does not tell you that you have cancer, and it does not tell you where.
"Detects more than 50 cancers" describes the list of cancer types the test was built and validated to look for. It does not mean the test finds 50 out of 50, and it does not mean it finds most cases of any one of them.
What the evidence shows
The largest study so far, the UK's NHS-Galleri trial, enrolled about 140,000 adults aged 50 to 77 and screened them once a year for three years. Results reported in 2026 missed the trial's own main goal: there was no statistically significant drop in cancers diagnosed at stage III or IV combined. The researchers did report more than 20% fewer stage IV diagnoses of 12 aggressive cancers in the later screening rounds, and about four times more cancers found than by standard screening alone. Deaths from cancer, the outcome that matters most, were not reported.
In the US PATHFINDER 2 study of nearly 36,000 adults aged 50 and over, the test rarely flagged healthy people: only about 0.4% of people without cancer got a positive result. Of 287 people with a cancer signal, 173 turned out to have cancer. But 440 cancers were diagnosed in the study overall, so most of them were not the ones the blood test found.
As of mid-2026, no MCED test is FDA-approved. Galleri is sold as a laboratory-developed test, largely out of pocket. Its maker submitted a premarket approval application in January 2026, and the FDA has not ruled on it. No professional guideline group and no USPSTF recommendation supports MCED testing for routine screening. NCI has launched the Vanguard Study to help design the trials that could answer the mortality question.
What this does not mean
A negative MCED result does not mean you are cancer-free. NCI's specific worry is that people who test negative will skip mammograms, colonoscopy, cervical screening or lung CT, tests that have been proven in trials to lower deaths. That trade would leave you worse off, not better.
A positive result is not a diagnosis either. It starts a workup of scans and sometimes biopsies, and in published studies of positive MCED results, more than half the time no cancer was found. That can mean weeks of fear, real cost, and procedures that carry their own risks.
There is also overdiagnosis to weigh: finding a cancer so slow-growing that it would never have caused trouble, then treating it anyway.
The bottom line
MCED blood tests are a genuinely promising technology in the middle of being tested, not a settled screening tool. They can find some cancers earlier, and they miss many. Whether that adds up to fewer cancer deaths is still unknown. If you are considering one, treat it as a possible addition to the screening your clinician already recommends, never a substitute for it, and ask in advance what would happen next if the result came back positive.
Sources
Words to know
Tap any term to see what it means.
Common questions
Is the Galleri test FDA-approved?
No. As of July 2026 it is sold as a laboratory-developed test, which does not go through FDA premarket review. GRAIL submitted a premarket approval application to the FDA in January 2026 and a decision has not been announced. An FDA Breakthrough Device designation, which the test received in 2018, is not the same as approval.
If my MCED test is negative, does that mean I do not have cancer?
No. These tests miss many cancers, including many early ones. In PATHFINDER 2, most of the cancers diagnosed during the study were not the ones the blood test flagged. A negative result is not a reason to skip the screening your clinician recommends.
What happens if the test says a cancer signal was detected?
It starts a workup, not a diagnosis. You would typically have imaging and sometimes a biopsy to look for the source. In published research on positive MCED results, more than half the time no cancer was found. That process carries cost, anxiety and the risks of the procedures themselves.
Do these tests help people live longer?
That has not been shown yet. Finding cancer earlier is not automatically the same as fewer deaths, because some cancers found early would never have caused harm and some aggressive ones progress regardless. Trials are ongoing, including NCI's Vanguard Study through the Cancer Screening Research Network.
Should I pay for one out of pocket?
That is a decision to make with your clinician. It is worth asking in advance what the follow-up would involve if the result were positive, who would coordinate it, what it would cost, and whether anything about your personal or family history changes the calculation.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Your next step
What the evidence shows about common cancer claims.
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the federal sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Written by: Cancer Explained Editorial TeamSources last checked: 2026-07-30Last updated: 2026-07-30Next planned review: 2027-07-30
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source verified. This page was created with AI assistance and checked against the sources listed on it. Source checking is not a medical review.
General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.
Human medical review: not completed. Cancer Explained is not clinician-reviewed, and that is a deliberate design choice rather than a gap we are waiting to close. We restate published federal guidance and cite it; the authority belongs to the source, not to us. That is why every page names where its claims come from — so you can verify us instead of trusting us. Use it to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source verified — This page was created with AI assistance and checked against the sources listed on it. Source checking is not a medical review.
Human medical review: not completed. Cancer Explained is not clinician-reviewed, and that is a deliberate design choice rather than a gap we are waiting to close. We restate published federal guidance and cite it; the authority belongs to the source, not to us. That is why every page names where its claims come from — so you can verify us instead of trusting us. Use it to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share